Impaired selective cytokine production by CD4(+) T cells in Common Variable Immunodeficiency associated with the absence of memory B cells

Clin Immunol. 2016 May:166-167:19-26. doi: 10.1016/j.clim.2016.03.013. Epub 2016 Apr 4.

Abstract

Common Variable Immunodeficiency (CVID) is a primary immunodeficiency characterized by B cell dysfunction and decreased serum immunoglobulin. CVID patients are classified by the absence or presence of memory B cells. In addition, T cell defects have been demonstrated in only a proportion of CVID patients. The aim of this study was to evaluate the function of CD4(+) T cells from CVID patients and its association with memory B cells. Patients were classified according to their Freiburg groups: group Ia and Ib, with decreased switched memory B cells (<0.4 of PBL), and group II, with normal B cell subsets. Their T cell function was evaluated after stimulation. We observed normal and even increased CD4(+) T cell proliferation in group Ia (p=0.0277). The proliferation positively correlated with the clinical severity score (r=0.4796). We observed lower levels of IL-17A and IL-10 in group Ia (p=0.0177, 0.0109) and Ib (p=0.0009, 0.0084) patients. Group Ib patients also had low levels of IL-13 and IL-9 (p=0.0169, 0.010). Group II patients had similar cytokine production to that of the controls. BAFFR expression was reduced in groups Ia (p=0.0001) and Ib (p=0.0002) and showed an inverse correlation with the severity score (p=0.0262; r=0.5371). ICOS expression was reduced in group Ia (p=0.0364), and PD-1 was increased in group Ib (p=0.0432) patients. This study shows a selective impairment in cytokine production in group Ia patients, which was more extensive than in group Ib patients. The impairment was associated with BAFFR expression in B cells, with ICOS and PD-1 in T cells and, remarkably, with the absence of memory B cells and with the disease severity. Our results suggest that the evaluation of cytokine expression by T cells in combination with the study of B cell memory could be important for understand the pathogenesis of CVID patients.

Keywords: Activation; Co-stimulation; Common variable immunodeficiency; Cytokine; Memory B cells; T helper cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • B-Cell Activation Factor Receptor / genetics
  • B-Cell Activation Factor Receptor / immunology*
  • B-Lymphocytes / immunology*
  • B-Lymphocytes / pathology
  • B7-H1 Antigen / genetics
  • B7-H1 Antigen / immunology
  • CTLA-4 Antigen / genetics
  • CTLA-4 Antigen / immunology
  • Cell Proliferation
  • Common Variable Immunodeficiency / genetics
  • Common Variable Immunodeficiency / immunology*
  • Common Variable Immunodeficiency / pathology
  • Cross-Sectional Studies
  • Female
  • Gene Expression Regulation
  • Humans
  • Immunologic Memory*
  • Inducible T-Cell Co-Stimulator Protein / genetics
  • Inducible T-Cell Co-Stimulator Protein / immunology*
  • Interleukin-10 / genetics
  • Interleukin-10 / immunology
  • Interleukin-13 / genetics
  • Interleukin-13 / immunology
  • Interleukin-17 / genetics
  • Interleukin-17 / immunology
  • Interleukin-9 / genetics
  • Interleukin-9 / immunology
  • Lymphocyte Activation
  • Lymphocyte Count
  • Male
  • Middle Aged
  • Primary Cell Culture
  • Programmed Cell Death 1 Receptor / genetics
  • Programmed Cell Death 1 Receptor / immunology*
  • Severity of Illness Index
  • Signal Transduction
  • T-Lymphocytes / immunology*
  • T-Lymphocytes / pathology

Substances

  • B-Cell Activation Factor Receptor
  • B7-H1 Antigen
  • CD274 protein, human
  • CTLA-4 Antigen
  • ICOS protein, human
  • IL10 protein, human
  • IL13 protein, human
  • IL17A protein, human
  • IL9 protein, human
  • Inducible T-Cell Co-Stimulator Protein
  • Interleukin-13
  • Interleukin-17
  • Interleukin-9
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • TNFRSF13C protein, human
  • Interleukin-10